Lincoral-S 222 mg/g + 444.7 mg/g powder for use in drinking water
Lincoral-S 222 mg/g + 444.7 mg/g powder for use in drinking water
Awtorizzat
- Spectinomycin sulfate tetrahydrate
- Lincomycin hydrochloride monohydrate
Informazzjoni dwar il-prodott
Isem tal-mediċina:
Lincoral-S 222 mg/g + 444.7 mg/g powder for use in drinking water
Speċi li fuqhom ser jintuża l-prodott:
Dettalji tal-prodott
Forma farmaċewtika:
-
Trab għal ma' l-ilma tax-xorb
Perjodu ta' rtirar skont ir-rotta tal-għoti:
-
In drinking water use
-
Chicken
-
Eggsno withdrawal periodNot for use in birds producing or intended to produce eggs for human consumption.
-
Meat and offal5dayAnimals must not be slaughtered for human consumption during treatment.
-
-
Pig
-
Meat and offal0dayAnimals must not be slaughtered for human consumption during treatment.
-
-
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
- QJ01FF52
Status tal-awtorizzazzjoni:
-
Valid
Tagħrif addizzjonali
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
- HuVepharma
Data tal-awtorizzazzjoni għall-kummerċjalizzazzjoni:
Siti ta’ manifattura b’rilaxx tal-lott:
- Huvepharma S.A.
Awtorità responsabbli:
- Health Products Regulatory Authority
Numru tal-awtorizzazzjoni:
- VPA10782/041/001
Data tal-bidla fl-istatus tal-awtorizzazzjoni:
Numru tal-proċedura:
- IE/V/0668/001
Stati Membri Kkonċernati:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet